A 37-year-old white woman on over 10 years of immunosuppressive therapy for two successive renal transplants was seen in our dermatology clinic for a tender lesion on her left eyebrow…

INTRODUCTION This edition of Resident Spotlight features Michael McLeod's winning poster,“Predictive Factors for Severity of Scar Formation After Skin Cancer Surgeries ” from the Orlando Dermatology Aesthetic & Clinical Conference…

Merkel Cell Carcinoma: Banal-Appearing, Aggressive Actor Abstract Merkel cell carcinoma is a rare but often deadly cutaneous malignancy. It carries a 40 percent five-year mortality rate, in contrast to 15…

INTRODUCTION Psoriasis affects nearly 7.5 million Americans and 125 million people worldwide.1 It exists in two phases: the acute, flaring state and the chronic, indolent state. We designate the acute…

BACKGROUNDDermatofibrosarcoma protuberans (DFSP) is an uncommon dermal and subcutaneous neoplasm with a predilection for the trunk of young to middle-aged adults. The tumor presents clinically as solitary or multiple skin-colored,…

INTRODUCTION Psoriasis is a chronic, immune-mediated, inflammatory skin disease that affects approximately 3% of the population in the United States (U.S.),1 or 6.4 million people.2 Recently, more emphasis has been…

INTRODUCTION Pruritus is a common aspect of many conditions including urticaria, psoriasis, atopic dermatitis, renal failure and cholestasis. It is generally recognized that pruritus has a profound effect on quality-of-life…

INTRODUCTIONPsoriasis is a chronic, immune-mediated, inflammatory condition that occurs worldwide; frequency varies greatly among different racial and ethnic groups.1,2 The prevalence of psoriasis has been estimated at 1.3 percent in…

INTRODUCTION Psoriasis is caused by the interplay of various cellular processes in the skin, including keratinocyte hyperplasia, vascular proliferation and lymphocyte infiltration.1 Its multi-factorial etiology calls for many therapeutic agents…

INTRODUCTION Etanercept is a fusion protein with affinity for soluble tumor necrosis factor alpha (TNF-a) that has been approved by the U.S. Food and Drug Administration (FDA) for the treatment…

The Department of Dermatology at the University of California, San Francisco (UCSF), was founded in the early 1960s, and has grown to include close to 40 full-time faculty members and…

INTRODUCTION Recent estimates suggest that psoriasis affects between two and 3.5 percent of adults in the United States (U.S.), which corresponds to approximately 4.5 million to 8 million adults.1,2 Scalp…